Skip to main content
. 2020 May 19;11:737. doi: 10.3389/fphar.2020.00737

Figure 6.

Figure 6

CCT020312 inhibited tumor growth in an MDA-MB-453 cell orthotopic xenograft mouse model. (A) Tumor volumes were measured every three days and differed at the end of the treatment period (n = 5). Data are presented as mean ± SD, *p < 0.01 vs. control. (B) Body weight changes in mice during the 21 days of CCT020312 treatment (n = 5). Data are presented as mean ± SD. (C) Representative tumor tissues were sectioned and subjected to immunohistochemistry staining (magnification, × 400). (D) Representative tumor tissues from each group were prepared and subjected to Western blotting assay.